-
-
-
-
-
-
-
Rhythm Pharmaceuticals schedules call on Prader-Willi syndrome trial data
-
-
-
-
-
-
-
Jazz's Zepzelca fails late-stage lung cancer trial
-
-
-
-
-
-
-
AbbVie presents nine-year venetoclax trial results at EHA congress
-
-
-
-
-
-
-
Tempus publishes validation study for FDA-cleared ECG AI model
-
-
-
-
-
-
-
Enliven Therapeutics reports phase 1 trial results for leukemia drug
-
-
-
-
-
-
-
BeOne presents phase 3 data showing BRUKINSA benefits in elderly CLL patients
-
-
-
-
-
-
-
Climb Bio reports initial phase 1b data for budoprutug in blood disorder
-
75,866 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

